Steris Healthcare Private Limited

Formoterol Fumarate Dihydrate IP 6 mcg & Budesonide IP 200 mcg is a combination inhalation medication designed for the effective management of asthma and chronic obstructive pulmonary disease (COPD). This formulation combines the long-acting bronchodilator Formoterol with the anti-inflammatory Budesonide, providing dual action to improve lung function, reduce inflammation, and prevent respiratory distress.

This combination inhaler is primarily prescribed for:

• Asthma Management – Helps in controlling persistent asthma symptoms and preventing asthma attacks.

• Chronic Obstructive Pulmonary Disease (COPD) – Aids in improving breathing, reducing flare-ups, and enhancing quality of life for COPD patients.

• Preventive Therapy – Suitable for long-term use to minimize airway inflammation and bronchospasms.

1. Dual Action Relief – Combines the bronchodilator effect of Formoterol with the anti-inflammatory benefits of Budesonide.

2. Improved Lung Function – Helps open airways and reduces wheezing, shortness of breath, and tightness in the chest.

3. Reduced Exacerbations – Lowers the frequency of asthma or COPD attacks.

4. Convenient Long-Acting Effect – Formoterol provides prolonged bronchodilation for up to 12 hours.

5. Anti-Inflammatory Support – Budesonide helps control airway inflammation, improving overall respiratory health.

While generally well-tolerated, some individuals may experience:

• Mild Side Effects: Throat irritation, cough, hoarseness, or mild tremors.

• Serious Side Effects (rare): Rapid heartbeat, chest pain, allergic reactions (rash, swelling, or breathing difficulty).

• Precaution: Always use as directed by a healthcare professional. Overuse can increase the risk of side effects.

• Use the inhaler regularly as prescribed for optimal benefits.

• Rinse your mouth after each use to reduce the risk of oral thrush.

• Not suitable for immediate relief of sudden asthma attacks—carry a rescue inhaler if prescribed.